The development of highly sensitive CRP assays (hs-CRP) has enabled the identification of more subtle elevations in CRP that may predict the increased risk of atherogenic cardiovascular diseases (CVD)[3,4] with better specificity than traditional risk factors such as low-density lipoprotein (LDL) cholesterol levels[4]. The gene discussed is CRP; the disease is cardiovascular disorder.